drugset / Trial / NCT01883011
A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study was to confirm the efficacy of piracetam after 12 weeks of treatment on the aphasic status of subjects suffering from aphasia after acute ischemic middle cerebral artery stroke and having received their medication within 7 h post-stroke onset.
Timeline
- Start
- 1998-08
- Primary completion
- 2001-07
- Completion
- 2001-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Piracetam | Small molecule | 4.8 g | Intravenous |